These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 33859172
1. Phenotypical differences and thrombosis rates in secondary erythrocytosis versus polycythemia vera. Nguyen E, Harnois M, Busque L, Sirhan S, Assouline S, Chamaki I, Olney H, Mollica L, Szuber N. Blood Cancer J; 2021 Apr 15; 11(4):75. PubMed ID: 33859172 [No Abstract] [Full Text] [Related]
2. Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis. Gordeuk VR, Key NS, Prchal JT. Haematologica; 2019 Apr 15; 104(4):653-658. PubMed ID: 30872370 [Abstract] [Full Text] [Related]
3. Screening for latent polycythemia vera in chronic obstructive pulmonary disease-associated erythrocytosis. Langabeer SE. Respir Med Res; 2022 May 15; 81():100914. PubMed ID: 35525098 [No Abstract] [Full Text] [Related]
4. Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. McMullin MF, Bareford D, Campbell P, Green AR, Harrison C, Hunt B, Oscier D, Polkey MI, Reilly JT, Rosenthal E, Ryan K, Pearson TC, Wilkins B, General Haematology Task Force of the British Committee for Standards in Haematology. Br J Haematol; 2005 Jul 15; 130(2):174-95. PubMed ID: 16029446 [No Abstract] [Full Text] [Related]
5. JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis. Martínez-Avilés L, Besses C, Alvarez-Larrán A, Cervantes F, Hernández-Boluda JC, Bellosillo B. Haematologica; 2007 Dec 15; 92(12):1717-8. PubMed ID: 18056003 [Abstract] [Full Text] [Related]
6. ST-Segment Elevation Myocardial Infarction and Bleeding Complications in JAK2-Negative Polycythemia. Duran Luciano P, Sabella-Jiménez V. Tex Heart Inst J; 2023 Oct 20; 50(5):. PubMed ID: 37872693 [Abstract] [Full Text] [Related]
7. [Erythremia and secondary erythrocytosis]. Derbeneva LI. Med Sestra; 1977 Aug 20; 36(8):47-9. PubMed ID: 271757 [No Abstract] [Full Text] [Related]
8. [Disorders of the major blood flow due to polycythemia vera]. Gribenko VV, Artemenko OV, Kucher VN, Dudko ET. Vrach Delo; 1988 Oct 20; (10):28-31. PubMed ID: 3218190 [No Abstract] [Full Text] [Related]
9. Polycythemia vera and idiopathic erythrocytosis: comparison of clinical and laboratory parameters. Usman M, Bilwani F, Kakepoto GN, Adil SN, Sajid R, Khurshid M. J Pak Med Assoc; 2004 May 20; 54(5):249-51. PubMed ID: 15270182 [Abstract] [Full Text] [Related]
10. [New criteria for differential diagnosis of polycythemia vera and erythrocytosis]. Velik LV, Udris OIu, Bondare DK. Gematol Transfuziol; 1992 May 20; 37(9-10):40-2. PubMed ID: 1490574 [Abstract] [Full Text] [Related]
11. Increased Lipocalin 2 level may have important role in thrombotic events in patients with polycythemia vera and essential thrombocythemia. Rajnics P, Kellner Á, Karádi É, Moizs M, Bödör C, Király PA, Marosvári D, Andrikovics H, Egyed M. Leuk Res; 2016 Sep 20; 48():101-6. PubMed ID: 27161323 [Abstract] [Full Text] [Related]
12. [Association between hepatocellular carcinoma and polycythemia vera]. Gensini GF, Conti AA. Recenti Prog Med; 2002 Jan 20; 93(1):25-7. PubMed ID: 11850996 [Abstract] [Full Text] [Related]
13. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea. Alvarez-Larrán A, Pérez-Encinas M, Ferrer-Marín F, Hernández-Boluda JC, Ramírez MJ, Martínez-López J, Magro E, Cruz Y, Mata MI, Aragües P, Fox ML, Cuevas B, Montesdeoca S, Hernández-Rivas JA, García-Gutiérrez V, Gómez-Casares MT, Steegmann JL, Durán MA, Gómez M, Kerguelen A, Bárez A, García MC, Boqué C, Raya JM, Martínez C, Albors M, García F, Burgaleta C, Besses C, Grupo Español de Neoplasias Mieloproliferativas Filadelfia Negativas. Haematologica; 2017 Jan 20; 102(1):103-109. PubMed ID: 27686377 [Abstract] [Full Text] [Related]
14. Erythrocytosis in a patient with chronic obstructive pulmonary disease. Vicari AM, Ponzoni M, Alberetto M, Martani C, Pontiroli AE, Folli F. Haematologica; 1998 Feb 20; 83(2):183-6. PubMed ID: 9549929 [Abstract] [Full Text] [Related]
15. Polycythemia vera--a case report and discussion on pathogenic mechanisms of increased thrombosis. Gumina RJ, Foley DA, Tefferi A, Rooke TW, Shields RC. Angiology; 2002 Feb 20; 53(5):587-91. PubMed ID: 12365868 [Abstract] [Full Text] [Related]
16. High red blood cell distribution width might predict thrombosis in essential thrombocythemia and polycythemia vera. Krečak I, Krečak F, Gverić-Krečak V. Blood Cells Mol Dis; 2020 Feb 20; 80():102368. PubMed ID: 31669934 [No Abstract] [Full Text] [Related]
17. Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia. Krecak I, Lekovic D, Grohovac D, Sabljic A, Holik H, Zekanovic I, Moric Peric M, Galusic D, Perisa V, Krecak F, Skelin M, Lucijanic M. Leuk Lymphoma; 2024 May 20; 65(5):688-691. PubMed ID: 38248137 [No Abstract] [Full Text] [Related]
18. The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis. Ruggeri M, Tosetto A, Frezzato M, Rodeghiero F. Ann Intern Med; 2003 Sep 16; 139(6):470-5. PubMed ID: 13679323 [Abstract] [Full Text] [Related]
19. Diagnosis of polycythemia vera in an anemic patient. Hassoun H, Pavlovsky M, Mansoor S, Stopka T. South Med J; 2000 Jul 16; 93(7):710-2. PubMed ID: 10923962 [Abstract] [Full Text] [Related]
20. No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cytoreductive Therapy in Polycythemia Vera clinical trials. Barbui T, Carobbio A, Ghirardi A, Masciulli A, Rambaldi A, Vannucchi AM. Haematologica; 2017 Jun 16; 102(6):e219-e221. PubMed ID: 28255021 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]